FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotech company engaged in the development of innovative gene therapies for the brain and central nervous system, today announced that John E. Mordock, president and chief executive officer of the Company, will present at the C.E. Untenberg, Towbin Life Sciences Conference to be held from October 30 - 31, 2006, in New York.
